Biotech Startups

BioAgilytix provides bioanalytical laboratory services supporting drug development across all phases, from preclinical through clinical studies. The company operates advanced facilities across North America, Europe, and Australia, specializing in large molecule bioanalysis, LC/MS testing, and diagnostic services for the biopharmaceutical industry.

1 investor

BioAlert Solutions develops qPCR-based monitoring systems for detecting Legionella in cooling towers and water systems across North America. The company serves industries, hospitals, and facility managers to enhance public health safety and ensure regulatory compliance.

1 investor

Bioarchitech develops oncolytic virus therapies and RNA-based immunotherapy candidates for cancer treatment. The company combines expertise in viral engineering, immunology, and preclinical development to advance novel therapeutic platforms.

1 investor

BioAscent provides integrated drug discovery services including medicinal chemistry, biosciences, computational discovery, and compound management. The company serves pharmaceutical and biotech clients requiring external research capabilities.

1 investor

BioAtlantis develops bioactive compounds extracted from seaweed and terrestrial resources to mitigate stress in plants, animals, and humans. The company serves the agricultural crop sector with naturally derived biostimulants and nutraceuticals designed to strengthen natural defence systems.

1 investor

Biobase builds data infrastructure to make clinical data accessible across the healthcare value chain, positioning itself as the "rails" for precision medicine rather than a data marketplace. It serves participants in the healthcare and life sciences sector by connecting data generated during care with downstream medicine development.

1 investor

BioBijou is a South Korean company in the K-beauty bio industry that uses biotechnology and R&D to develop medical aesthetic products. It focuses on expanding its product portfolio and global network in the medical aesthetics space.

1 investor

BioBlends develops biopreservation products that use volatile organic compounds from beneficial bacteria, combined with bioinformatics and experimental validation, to control preservative-resistant microorganisms and fungal contamination in food. Its solutions extend shelf life across food matrices without chemical residues, serving industrial food producers such as baked goods manufacturers.

1 investor

Biocare Medical develops automated immunohistochemistry and molecular pathology instrumentation and reagents for tissue diagnostic testing. The company serves clinical and research laboratories, pharmaceutical companies, and biotechnology firms conducting cancer and infectious disease diagnostics.

1 investor

Biocartesian provides optical pooled screening services for functional genomics research. The company uses its proprietary ARADIA technology to link microscopy-based cellular phenotypes with genetic perturbations, enabling researchers to conduct large-scale CRISPR screens and other genomic studies with visual, spatial, and live-cell readouts.

1 investor

BioCell Analytica provides effect-based analysis using cultured cells to detect health- and environment-hazardous contaminants in water, soil, and sediment, capturing the combined "cocktail effect" of multiple substances. It serves the water industry for testing drinking water, wastewater treatment efficiency, and chemical pollution monitoring.

1 investor

Biocellis develops a patented bioluminescence immunoassay platform that delivers laboratory-grade, picogram-level sensitivity with results in under 60 seconds in a compact, portable format for point-of-care and high-throughput screening. Its diagnostics target human health, veterinary, environmental, food safety, and public screening applications across hospitals, clinics, and field settings.</parameter> <parameter name="founders">[{"full_name": "Vincent Poher", "title": "Co-founder", "linkedin_url": "https://www.linkedin.com/in/vincentpoher/"}, {"full_name": "Thierry Rose", "title": "Co-founder", "linkedin_url": "https://www.linkedin.com/in/thierry-rose-122013254/"}, {"full_name": "Sophie Goyard", "title": "Co-founder", "linkedin_url": "https://www.linkedin.com/in/sophie-goyard-968844103/"}]</parameter> <parameter name="hq_city">Grenoble

1 investor

Bioceres Crops develops and commercializes agricultural productivity solutions—including patented seed technologies (such as its HB4 drought-tolerant program), microbial ag-inputs, crop nutrition and protection products, and digital tools for growers. It serves farmers and agricultural stakeholders with technologies aimed at improving crop resilience to climate change and enabling production traceability.

1 investor

BioChange develops CellFoam, a biodegradable and biocompatible foam scaffold technology for regenerative medicine that supports tissue repair and organ recovery. Its product lines target dental, aesthetic, and human medical uses as well as veterinary care (including products like ReFoam, Revolette, ReGumVet, VetFoam, and vitaloc), with its veterinary line already in the U.S. market.

1 investor

BioChip Labs provides laboratory testing services for blood disorders, including sickle cell disease and thalassemia, using traditional and proprietary blood cell analysis methods. The company conducts comprehensive biomarker assays and works with clinicians and researchers.

1 investor

BioCircuit Technologies develops advanced medical devices for tissue repair and neuromodulation, with specialization in biomaterials, nitinol design, and bioelectronics. The company serves surgical teams with products like Nerve Tape®, a sutureless device for nerve repair.

1 investor

BioClé is a biotechnology company developing a delivery platform based on bacterial extracellular vesicles (bEVs) to improve the stability, bioavailability, and cellular uptake of bioactive compounds.

1 investor

BioCloak develops fully biodegradable bio-based encapsulation and coating technologies to replace petroleum-based polymers used for the controlled release of pesticides, fertilizers, and nutrients. It serves agrochemical and animal nutrition companies, aiming to reduce microplastic pollution in agriculture, landscaping, and animal nutrition applications.

1 investor

BioCompute is developing DNA-based data storage technology, offering exclusive pilot programs for early access. The company operates in the data storage and biotechnology space.

1 investor

Bioconnect Systems was a medical-device company based in Ambler, PA that developed sutureless vascular connectors, including its Optiflow anastomotic system, to improve dialysis access surgery.

1 investor

Biocrates develops standardized metabolomics kit technology and software for quantitative metabolic profiling, used to study biosamples across many biological questions. It serves scientists and researchers in pharma, academia, and health institutions, along with core facilities and CROs.

1 investor

BioCryst is a global biotechnology company focused on drug discovery, development, and commercialization of oral small-molecule and injectable protein therapeutics. It develops novel medicines for patients with hereditary angioedema (HAE) and other rare diseases.

1 investor

Biocytogen (HKEX: 02315) is a global biotechnology company that uses genetically engineered mouse models and its RenMice/RenMab/RenNano fully human antibody platforms to develop therapeutic antibody drugs. It provides antibody discovery, humanized mouse models (e.g. B-NDG, immune checkpoint humanized mice), and preclinical pharmacology and CRO services to biopharma clients worldwide.

1 investor

BioDefense makes portable sensors that detect pathogens at the point of sampling in food and water. The devices test for several targets at once and return results in roughly 15 minutes, which shortens the wait associated with sending samples to a laboratory. Customers are industrial food and water operations managing contamination risk.

1 investor